| Literature DB >> 23174137 |
Alberto Pagnamenta1, Giovanni Rabito, Alessandra Arosio, Andreas Perren, Roberto Malacrida, Fabrizio Barazzoni, Guido Domenighetti.
Abstract
BACKGROUND: Adverse events (AEs) frequently occur in intensive care units (ICUs) and affect negatively patient outcomes. Targeted improvement strategies for patient safety are difficult to evaluate because of the intrinsic limitations of reporting crude AE rates. Single interventions influence positively the quality of care, but a multifaceted approach has been tested only in selected cases. The present study was designed to evaluate the rate, types, and contributing factors of emerging AEs and test the hypothesis that a multifaceted intervention on medication might reduce drug-related AEs.Entities:
Year: 2012 PMID: 23174137 PMCID: PMC3526522 DOI: 10.1186/2110-5820-2-47
Source DB: PubMed Journal: Ann Intensive Care ISSN: 2110-5820 Impact factor: 6.925
Figure 1Study design. Staff training in adverse events (AE) reporting during 2 months before the pre-implementation period (May 1, 2004 to April 30, 2005). The multifaceted intervention on drug-related AEs was arranged 6 months before its definitive introduction into clinical practice (May 1, 2005). The three structured meetings with the caring staff took place during the same week in the four ICUs.
Patient characteristics
| No. of patients | 3111 | 3293 | 6404 |
| Age (yr), mean ± SD | 64.6 ± 17.5 | 63.2 ± 18.2 | 63.8 ± 17.9 |
| Male sex, n (%) | 1743 (56) | 1975 (60) | 3718 (58) |
| SAPS II at admission, mean ± SD | 34.2 ± 17.3 | 36.8 ± 17.8 | 35.5 ± 17.6 |
| Type of admission, n (%) | | | |
| Medical | 2180 (70) | 2173 (66) | 4353 (68) |
| Scheduled surgery | 465 (15) | 590 (18) | 1055 (16.5) |
| Unscheduled surgery | 466 (15) | 530 (17) | 996 (15.5) |
| Principal reason for admission to unit, n (%) | | | |
| Cardiovascular disorders | 872 (28) | 985 (30) | 1857 (29) |
| Respiratory disorders | 531 (17) | 461 (14) | 992 (15.5) |
| Neurological disorders | 373 (12) | 421 (12.8) | 794 (12.4) |
| Gastrointestinal disorders | 292 (9.4) | 336 (10.2) | 628 (9.8) |
| Trauma | 311 (10) | 290 (8.8) | 601 (9.4) |
| Intoxication | 155 (5) | 165 (5) | 320 (5) |
| Metabolic disorders | 124 (4) | 132 (4) | 256 (4) |
| Other | 452 (14.5) | 504 (15.3) | 956 (14.9) |
| Length of ICU stay, days | | | |
| Mean ± SD | 2.8 ± 5.3 | 2.9 ± 5.2 | 2.8 ± 5.3 |
| Median (25th percentile, 75th percentile) | 1.4 (1.0, 3) | 1.1(0.8, 2.5) | 1.2 (0.8, 2.7) |
| ICU mortality, n (%) | 182 (5.8) | 176 (5.3) | 358 (5.6) |
Data are presented for the pre-implementation period (first 12 months) for the post-implementation period (last 12 months), and for the whole study period (24 months). ICU, intensive care unit; SAPS, simplified acute physiology score; SD, standard deviation.
Adverse events characteristics
| No. of AEs | 1071 | 976 | 2047 |
| Person reporting, n (%) | | | |
| Nurse | 869 (81) | 888 (91) | 1757 (86) |
| MD | 190 (18) | 79 (8) | 269 (13) |
| Other | 12 (1) | 9 (1) | 21 (1) |
| Role of reporter, n (%) | | | |
| Eye-witnessed the AE | 494 (46) | 509 (52) | 1003 (49) |
| Involved in AE occurrence | 395 (37) | 321 (33) | 716 (35) |
| Was called for help | 138 (13) | 129 (13) | 267 (13) |
| Missing data | 30 (3) | 31 (3) | 61 (3) |
| Patients NEMS in AEs questionnaire, n (%) | | | |
| NEMS ≥25 | 227 (21) | 203 (21) | 430 (21) |
| NEMS 22-24 | 450 (42) | 430 (44) | 880 (43) |
| NEMS 14-21 | 302 (28) | 251 (26) | 553 (27) |
| NEMS <14 | 42(4) | 40 (4) | 82 (4) |
| NEMS, missing data | 62 (6) | 40 (4) | 102 (5) |
| Patients leading diagnosis in AEs questionnaire, n (%) | | | |
| >1 leading diagnosis | 446 (42) | 332 (34) | 778 (38) |
| Respiratory disorders | 204 (19) | 213 (22) | 409 (20) |
| Cardiovascular disorders | 176 (16) | 172 (18) | 348 (17) |
| Neurological disorders | 77 (7) | 66 (7) | 143 (7) |
| Postoperative | 60 (6) | 63 (6) | 123 (6) |
| Other | 134 (13) | 112 (11) | 246 (12) |
| AE categories, n (%) | | | |
| Drug-related | 506 (47) | 478 (49) | 984 (48) |
| Indwelling lines, catheters and drains | 135 (13) | 110 (11) | 245 (12) |
| Communication and planning | 107 (10) | 104 (11) | 213 (10) |
| Airway | 100 (9) | 88 (9) | 188 (9) |
| Equipment | 75 (7) | 89 (9) | 164 (8) |
| Other procedures (bronchoscopy, EGD, electrical cardioversion…) | 75 (7) | 60 (6) | 135 (7) |
| Others (documentation, positioning…) | 64 (6) | 54 (6) | 118 (6) |
Data are presented for the pre-implementation period (first 12 months), for the post-implementation period (last 12 months), and for the whole study period (24 months). AE, adverse event; EGD, esophagogastroduodenoscopy; NEMS, nine equivalents of nursing manpower use score; MD, medical doctor.
Figure 2Distribution of adverse events (AEs) during the day. Most reported AEs occurred between 08:00 and 12:00 a.m., with a peak around 10:00 am. Horizontal dashed line (at 1.8145 AEs/hour) indicates the limit of statistical significant among comparisons of means AEs per hour. SEM, standard error of the mean.
Characteristics of drug-related adverse events
| No. of drug-related AEs | 984 |
| Incorrect prescription, n (%) | 226 (23) |
| Inconsistency between prescription and administration, n (%) | 207 (21) |
| Wrong time dosage, n (%) | 197 (20) |
| Incorrect administration technique, n (%) | 128 (13) |
| Mistaken time of administration, n (%) | 98 (10) |
| Wrong initial dosage, n (%) | 59 (6) |
| Wrong preparation, n (%) | 49 (5) |
| Other, n (%) | 20 (2) |
AE, adverse event.
Risk-index score analysis as a function of time: before (first 12-month period) and after (last 12-month period) the introduction of a multifaceted strategy targeting medication
| Medication, mean ± SD | 10.01 ± 2.7 | 8.72 ± 3.52 | 1.29 (0.88-1.7) | <0.01 |
| Airway, mean ± SD | 9.22 ± 1.52 | 8.69 ± 1.83 | 0.53 (−0.92-1.98) | 0.46 |
| Indwelling lines, mean ± SD | 10.41 ± 2.79 | 9.2 ± 3.82 | 1.21 (−0.41-2.47) | 0.058 |
| Communication, mean ± SD | 9.29 ± 2.78 | 7.03 ± 3.22 | 2.26 (1.1-3.42) | <0.01 |
SD, standard deviation; CI, confidence interval.
Figure 3Mean monthly reporting rates of adverse events (AEs) during the entire study period (24 months). Vertical dashed lines indicate the occurrence of structured meetings with the care staff. After each meeting, an increase in AE reporting occurred.